Korea, Republic of (KR)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The Songdo consensus: Development of minimum reporting standards for studies of intervention in idiopathic anal fistula using a modified nominal group technique (2025) Joshi S, Hanna L, Cho DH, Garg P, Glyn T, Gurland B, Hwang DY, et al. Journal article Low-dose computed tomography perceptual image quality assessment (2025) Lee W, Wagner F, Galdran A, Shi Y, Xia W, Wang G, Mou X, et al. Journal article Mechanical behavior of BCC-superalloys (2025) Wang Q, Wang Z, Wang R, Knowles AJ, Zenk C, Song G, Lee C, et al. Journal article Guidelines Against Discrimination and Bias in Anatomical Research Papers (GDBARP): Recommendations From Anatomical Journal Editors (2025) Iwanaga J, Takeda S, Walocha JA, Ribatti D, del Sol M, Ravi KS, Moryś J, et al. Journal article Inverse design workflow discovers hole-transport materials tailored for perovskite solar cells (2024) Wu J, Torresi L, Hu M, Reiser P, Zhang J, Rocha-Ortiz JS, Wang L, et al. Journal article Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials (2024) Peyrin‐Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola , Jahnsen J, et al. Journal article Bi-allelic variants in CELSR3 are implicated in central nervous system and urinary tract anomalies (2024) Stegmann JD, Kalanithy JC, Dworschak GC, Ishorst N, Mingardo E, Lopes FM, Ho YM, et al. Journal article METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII (2024) Kocak B, Akinci D’Antonoli T, Mercaldo N, Alberich-Bayarri A, Baessler B, Ambrosini I, Andreychenko AE, et al. Journal article Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (2024) Schmid P, Cortes J, Dent R, Mcarthur H, Pusztai L, Kümmel S, Denkert C, et al. Journal article Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)] (2024) de Azambuja E, Piccart-Gebhart M, Fielding S, Townend J, Hillman DW, Colleoni M, Roylance R, et al. Journal article